Award
NIH Reporter #3U01CA294757-03S1
The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention among Women Living with HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation Trial
Recipient
Baylor University
Award Amount
$164,797.00
Ceiling
$164,797.00
Awarded
September 04, 2026
Identifier
3U01CA294757-03S1
A NIH/NCI funded project to develop and evaluate HPV self-sampling implementation strategies to increase cervical cancer screening among women living with HIV in Ghana, using a hybrid type 2 effectiveness-implementation randomized controlled trial.
Description
This project involves developing and evaluating implementation strategies for HPV self-sampling to increase cervical cancer screening among women living with HIV in Ghana. It is a hybrid type 2 effectiveness-implementation randomized controlled trial leveraging existing relationships with health facilities in Ghana.